0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertussis Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Othe-4136
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pertussis Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pertussis Vaccine Market Research Report 2024

Code: QYRE-Othe-4136
Report
January 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pertussis Vaccine Market Size

The global Pertussis Vaccine market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6619.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.

Pertussis Vaccine Market

Pertussis Vaccine Market

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.

Report Scope

The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pertussis Vaccine Market Report

Report Metric Details
Report Name Pertussis Vaccine Market
Accounted market size in 2023 US$ 5187.9 million
Forecasted market size in 2030 US$ 6619.4 million
CAGR 3.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Whole-cell Vaccines
  • Acellular Vaccines
Segment by Application
  • 12 Months Below
  • 12 Months Above
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pertussis Vaccine Market growing?

Ans: The Pertussis Vaccine Market witnessing a CAGR of 3.5% during the forecast period 2024-2030.

What is the Pertussis Vaccine Market size in 2030?

Ans: The Pertussis Vaccine Market size in 2030 will be US$ 6619.4 million.

What is the market share of major companies in Pertussis Vaccine Market?

Ans: Global top 2 manufacturers hold a share about 90%.

Who are the main players in the Pertussis Vaccine Market report?

Ans: The main players in the Pertussis Vaccine Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products

What are the Application segmentation covered in the Pertussis Vaccine Market report?

Ans: The Applications covered in the Pertussis Vaccine Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Pertussis Vaccine Market report?

Ans: The Types covered in the Pertussis Vaccine Market report are Whole-cell Vaccines, Acellular Vaccines

1 Pertussis Vaccine Market Overview
1.1 Product Overview and Scope of Pertussis Vaccine
1.2 Pertussis Vaccine Segment by Type
1.2.1 Global Pertussis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Pertussis Vaccine Segment by Application
1.3.1 Global Pertussis Vaccine Market Value by Application: (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Pertussis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pertussis Vaccine Revenue 2019-2030
1.4.2 Global Pertussis Vaccine Sales 2019-2030
1.4.3 Global Pertussis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pertussis Vaccine Market Competition by Manufacturers
2.1 Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pertussis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Pertussis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertussis Vaccine, Product Type & Application
2.7 Pertussis Vaccine Market Competitive Situation and Trends
2.7.1 Pertussis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pertussis Vaccine Players Market Share by Revenue
2.7.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pertussis Vaccine Retrospective Market Scenario by Region
3.1 Global Pertussis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pertussis Vaccine Global Pertussis Vaccine Sales by Region: 2019-2030
3.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
3.2.2 Global Pertussis Vaccine Sales by Region: 2025-2030
3.3 Global Pertussis Vaccine Global Pertussis Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pertussis Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pertussis Vaccine Revenue by Region: 2025-2030
3.4 North America Pertussis Vaccine Market Facts & Figures by Country
3.4.1 North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pertussis Vaccine Sales by Country (2019-2030)
3.4.3 North America Pertussis Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pertussis Vaccine Market Facts & Figures by Country
3.5.1 Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pertussis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pertussis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pertussis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pertussis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pertussis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pertussis Vaccine Sales by Type (2019-2030)
4.1.1 Global Pertussis Vaccine Sales by Type (2019-2024)
4.1.2 Global Pertussis Vaccine Sales by Type (2025-2030)
4.1.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pertussis Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pertussis Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pertussis Vaccine Sales by Application (2019-2030)
5.1.1 Global Pertussis Vaccine Sales by Application (2019-2024)
5.1.2 Global Pertussis Vaccine Sales by Application (2025-2030)
5.1.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pertussis Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pertussis Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Corporation Information
6.4.2 Wuhan Institute of Biological Products Description and Business Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Corporation Information
6.6.2 Minhai Biotechnology Description and Business Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
6.6.5 Minhai Biotechnology Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Pertussis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 Chengdu Institute of Biological Products
6.8.1 Chengdu Institute of Biological Products Corporation Information
6.8.2 Chengdu Institute of Biological Products Description and Business Overview
6.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertussis Vaccine Industry Chain Analysis
7.2 Pertussis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertussis Vaccine Production Mode & Process
7.4 Pertussis Vaccine Sales and Marketing
7.4.1 Pertussis Vaccine Sales Channels
7.4.2 Pertussis Vaccine Distributors
7.5 Pertussis Vaccine Customers
8 Pertussis Vaccine Market Dynamics
8.1 Pertussis Vaccine Industry Trends
8.2 Pertussis Vaccine Market Drivers
8.3 Pertussis Vaccine Market Challenges
8.4 Pertussis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Pertussis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Pertussis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Pertussis Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Pertussis Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Pertussis Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Pertussis Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Pertussis Vaccine Average Price (USD/Doses) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Pertussis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Pertussis Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pertussis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 18. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 20. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 27. North America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 28. North America Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 32. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 33. Europe Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 37. Asia Pacific Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 38. Asia Pacific Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 42. Latin America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 43. Latin America Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 47. Middle East & Africa Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 48. Middle East & Africa Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Pertussis Vaccine Sales (M Doses) by Type (2019-2024)
    Table 51. Global Pertussis Vaccine Sales (M Doses) by Type (2025-2030)
    Table 52. Global Pertussis Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Pertussis Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Pertussis Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Pertussis Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Pertussis Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Pertussis Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Pertussis Vaccine Price (USD/Doses) by Type (2019-2024)
    Table 59. Global Pertussis Vaccine Price (USD/Doses) by Type (2025-2030)
    Table 60. Global Pertussis Vaccine Sales (M Doses) by Application (2019-2024)
    Table 61. Global Pertussis Vaccine Sales (M Doses) by Application (2025-2030)
    Table 62. Global Pertussis Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Pertussis Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Pertussis Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Pertussis Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Pertussis Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Pertussis Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Pertussis Vaccine Price (USD/Doses) by Application (2019-2024)
    Table 69. Global Pertussis Vaccine Price (USD/Doses) by Application (2025-2030)
    Table 70. Sanofi Pasteur Corporation Information
    Table 71. Sanofi Pasteur Description and Business Overview
    Table 72. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 73. Sanofi Pasteur Pertussis Vaccine Product
    Table 74. Sanofi Pasteur Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 78. GSK Pertussis Vaccine Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Mitsubishi Tanabe Pharma Corporation Information
    Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
    Table 82. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 83. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
    Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
    Table 85. Wuhan Institute of Biological Products Corporation Information
    Table 86. Wuhan Institute of Biological Products Description and Business Overview
    Table 87. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 88. Wuhan Institute of Biological Products Pertussis Vaccine Product
    Table 89. Wuhan Institute of Biological Products Recent Developments/Updates
    Table 90. Walvax Biotechnology Corporation Information
    Table 91. Walvax Biotechnology Description and Business Overview
    Table 92. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 93. Walvax Biotechnology Pertussis Vaccine Product
    Table 94. Walvax Biotechnology Recent Developments/Updates
    Table 95. Minhai Biotechnology Corporation Information
    Table 96. Minhai Biotechnology Description and Business Overview
    Table 97. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 98. Minhai Biotechnology Pertussis Vaccine Product
    Table 99. Minhai Biotechnology Recent Developments/Updates
    Table 100. KM Biologics Corporation Information
    Table 101. KM Biologics Description and Business Overview
    Table 102. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 103. KM Biologics Pertussis Vaccine Product
    Table 104. KM Biologics Recent Developments/Updates
    Table 105. Chengdu Institute of Biological Products Corporation Information
    Table 106. Chengdu Institute of Biological Products Description and Business Overview
    Table 107. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
    Table 108. Chengdu Institute of Biological Products Pertussis Vaccine Product
    Table 109. Chengdu Institute of Biological Products Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Pertussis Vaccine Distributors List
    Table 113. Pertussis Vaccine Customers List
    Table 114. Pertussis Vaccine Market Trends
    Table 115. Pertussis Vaccine Market Drivers
    Table 116. Pertussis Vaccine Market Challenges
    Table 117. Pertussis Vaccine Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Pertussis Vaccine
    Figure 2. Global Pertussis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Pertussis Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Whole-cell Vaccines Product Picture
    Figure 5. Acellular Vaccines Product Picture
    Figure 6. Global Pertussis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Pertussis Vaccine Market Share by Application in 2023 & 2030
    Figure 8. 12 Months Below
    Figure 9. 12 Months Above
    Figure 10. Global Pertussis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
    Figure 13. Global Pertussis Vaccine Average Price (USD/Doses) & (2019-2030)
    Figure 14. Pertussis Vaccine Report Years Considered
    Figure 15. Pertussis Vaccine Sales Share by Manufacturers in 2023
    Figure 16. Global Pertussis Vaccine Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Pertussis Vaccine Players: Market Share by Revenue in 2023
    Figure 18. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Pertussis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Pertussis Vaccine Sales Market Share by Country (2019-2030)
    Figure 21. North America Pertussis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Pertussis Vaccine Sales Market Share by Country (2019-2030)
    Figure 25. Europe Pertussis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Pertussis Vaccine Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Pertussis Vaccine Revenue Market Share by Region (2019-2030)
    Figure 33. China Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Taiwan Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Philippines Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Pertussis Vaccine Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Pertussis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Pertussis Vaccine Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Pertussis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. U.A.E Pertussis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Pertussis Vaccine by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Pertussis Vaccine by Type (2019-2030)
    Figure 55. Global Pertussis Vaccine Price (USD/Doses) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Pertussis Vaccine by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Pertussis Vaccine by Application (2019-2030)
    Figure 58. Global Pertussis Vaccine Price (USD/Doses) by Application (2019-2030)
    Figure 59. Pertussis Vaccine Value Chain
    Figure 60. Pertussis Vaccine Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS